Biomarkers for glioblastoma multiforme: status quo

BACKGROUND: Glioblastoma (GBM) is the most frequent and most malignant central nervous system (CNS) tumor. GBM shows poor prognosis with a median overall survival of 14.6 months, despite current surgical and adjuvant therapies. O(6)-methylguanine-DNA methyltransferase (MGMT) methylation is the stron...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Transl Res
Autors principals: Montano, Nicola, D’Alessandris, Quintino Giorgio, Izzo, Alessandro, Fernandez, Eduardo, Pallini, Roberto
Format: Artigo
Idioma:Inglês
Publicat: Whioce Publishing Pte. Ltd. 2016
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410643/
https://ncbi.nlm.nih.gov/pubmed/30873456
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars